CAS 1359940-55-8

Tarextumab

CAS: 1359940-55-8

Fully human monoclonal antibody targeting Notch 2 and Notch 3 receptors, pancreatic and lung cancer treatment

Ref: 3D-CLA1334

Tarextumab

CAS: 1359940-55-8

Tarextumab is an anti-Notch2/3 mAb, a promising candidate for breast, lung, ovarian, and pancreatic cancers.

Reinheit: 95%

Farbe und Form: Liquid

Molekulargewicht: ~150 kDa

Ref: TM-T76829